{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:55:44Z","timestamp":1771667744619,"version":"3.50.1"},"reference-count":59,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Todos Por Quem Cuida (TPQC)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetology"],"abstract":"<jats:p>Metabolic syndrome (MS), a complex pathology with features like abnormal body fat distribution, insulin resistance, and dyslipidaemia, contributes to higher cardiovascular (CV) risk. A cross-sectional study including 87 individuals assessed CV risk score in elderly patients with type 2 diabetes and MS in Algarve, Portugal. The 10-year CV risk score was estimated using the ADVANCE risk score calculator. The reductions in CV risk score were estimated by adjusting the data inputted on the online tool to achieve systolic blood pressure (SBP) &lt;130 or &lt;120 mmHg, and LDL cholesterol &lt;70 mg\/dL Beyond waist circumference, the mean number of clinical features of MS was 3.14 \u00b1 0.84, without significant sex differences. The mean CV risk score was 22.5% (CI: 20.3\u201324.7). Sex-specific analysis showed higher risk score in males (24.2%, CI: 21.3\u201327.0) vs. females (19.7%, CI: 16.2\u201323.3; p = 0.028). Hypothetical risk score reductions show that lowering SBP to &lt;130 mmHg could significantly lower the risk score by an average of 9.2% (CI: 7.7\u201310.7), whereas 34.5% of the participants would be out of the diagnostic criteria for MS. When comparing each potential intervention with current risk score, all interventions significantly reduce the 10-year CV risk score. The study highlights the potential of blood pressure control in reducing CV risk score and the importance of multifaceted risk score reduction strategies.<\/jats:p>","DOI":"10.3390\/diabetology5030024","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T18:04:59Z","timestamp":1722535499000},"page":"321-332","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potential Impact of Metabolic Syndrome Control on Cardiovascular Risk in Elderly Patients with Diabetes: A Cross-Sectional Study"],"prefix":"10.3390","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2429-7374","authenticated-orcid":false,"given":"T\u00e2nia","family":"Nascimento","sequence":"first","affiliation":[{"name":"Escola Superior de Sa\u00fade, Universidade do Algarve (ESSUAlg), Campus de Gambelas, 8005-139 Faro, Portugal"},{"name":"Algarve Biomedical Centre Research Institute (ABC-RI), Campus de Gambelas, 8005-139 Faro, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2200-0015","authenticated-orcid":false,"given":"Margarida","family":"Esp\u00edrito-Santo","sequence":"additional","affiliation":[{"name":"Escola Superior de Sa\u00fade, Universidade do Algarve (ESSUAlg), Campus de Gambelas, 8005-139 Faro, Portugal"},{"name":"Algarve Biomedical Centre Research Institute (ABC-RI), Campus de Gambelas, 8005-139 Faro, Portugal"}]},{"given":"Adriana","family":"Gon\u00e7alves","sequence":"additional","affiliation":[{"name":"Escola Superior de Sa\u00fade, Universidade do Algarve (ESSUAlg), Campus de Gambelas, 8005-139 Faro, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9322-2937","authenticated-orcid":false,"given":"Ezequiel","family":"Pinto","sequence":"additional","affiliation":[{"name":"Escola Superior de Sa\u00fade, Universidade do Algarve (ESSUAlg), Campus de Gambelas, 8005-139 Faro, Portugal"},{"name":"Algarve Biomedical Centre Research Institute (ABC-RI), Campus de Gambelas, 8005-139 Faro, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8451-4302","authenticated-orcid":false,"given":"Ana Lu\u00edsa","family":"De Sousa-Coelho","sequence":"additional","affiliation":[{"name":"Escola Superior de Sa\u00fade, Universidade do Algarve (ESSUAlg), Campus de Gambelas, 8005-139 Faro, Portugal"},{"name":"Algarve Biomedical Centre Research Institute (ABC-RI), Campus de Gambelas, 8005-139 Faro, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7151-8363","authenticated-orcid":false,"given":"Maria Dulce","family":"Est\u00eav\u00e3o","sequence":"additional","affiliation":[{"name":"Escola Superior de Sa\u00fade, Universidade do Algarve (ESSUAlg), Campus de Gambelas, 8005-139 Faro, Portugal"},{"name":"Algarve Biomedical Centre Research Institute (ABC-RI), Campus de Gambelas, 8005-139 Faro, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic Syndrome-a New World-Wide Definition. A Consensus Statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4239\/wjd.v6.i6.850","article-title":"Diabetes Mellitus: The Epidemic of the Century","volume":"6","author":"Kharroubi","year":"2015","journal-title":"World J. Diabetes"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2024). 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142024. Diabetes Care, 47, S20\u2013S42.","DOI":"10.2337\/dc24-S002"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/1570161117666190502103733","article-title":"Microvascular Complications of Type 2 Diabetes Mellitus","volume":"18","author":"Faselis","year":"2020","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1042\/CS20160998","article-title":"Sex Differences in Micro- and Macro-Vascular Complications of Diabetes Mellitus","volume":"131","year":"2017","journal-title":"Clin. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00125-019-05040-3","article-title":"Sex Differences in Metabolic Regulation and Diabetes Susceptibility","volume":"63","author":"Tramunt","year":"2020","journal-title":"Diabetologia"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2174\/1573403X15666191111123622","article-title":"Assessing Cardiovascular Risk in Patients with Diabetes: An Update","volume":"16","author":"Damaskos","year":"2020","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s11886-024-02055-0","article-title":"Unexplained Residual Risk In Type 2 Diabetes: How Big Is The Problem?","volume":"26","author":"Neppala","year":"2024","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"117269","DOI":"10.1016\/j.atherosclerosis.2023.117269","article-title":"Sex-Specific Differences in Cardiovascular Risk Factors and Implications for Cardiovascular Disease Prevention in Women","volume":"384","author":"Rajendran","year":"2023","journal-title":"Atherosclerosis"},{"key":"ref_10","unstructured":"(2024, May 05). PORDATA \u00cdndice de Envelhecimento. Available online: https:\/\/www.pordata.pt\/Europa\/%C3%8Dndice+de+envelhecimento-1609."},{"key":"ref_11","unstructured":"Sociedade Portuguesa de Diabetologia (2023). Diabetes: Factos e N\u00fameros\u2014O Ano de 2019, 2020 e 2021\u2014Relat\u00f3rio Anual Do Observat\u00f3rio Nacional Da Diabetes 03\/2023, Sociedade Portuguesa de Diabetologia."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pcad.2010.04.001","article-title":"The Framingham Heart Study\u2019s Impact on Global Risk Assessment","volume":"53","author":"Bitton","year":"2010","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12529-016-9583-6","article-title":"2016 European Guidelines on Cardiovascular Disease Prevention in Clinical Practice","volume":"24","author":"Piepoli","year":"2016","journal-title":"Int. J. Behav. Med."},{"key":"ref_14","first-page":"j2099","article-title":"Development and Validation of QRISK3 Risk Prediction Algorithms to Estimate Future Risk of Cardiovascular Disease: Prospective Cohort Study","volume":"357","author":"Coupland","year":"2017","journal-title":"BMJ"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Badawy, M.A.E.M.D., Naing, L., Johar, S., Ong, S., Rahman, H.A., Tengah, D.S.N.A.P., Chong, C.L., and Tuah, N.A.A. (2022). Evaluation of Cardiovascular Diseases Risk Calculators for CVDs Prevention and Management: Scoping Review. BMC Public Health, 22.","DOI":"10.1186\/s12889-022-13944-w"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijmedinf.2004.05.011","article-title":"Cardiovascular Risk Calculators: Understanding Differences and Realising Economic Implications","volume":"74","author":"Quaglini","year":"2005","journal-title":"Int. J. Med. Inform."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.repc.2015.11.002","article-title":"Cardiovascular Risk Scores: Usefulness and Limitations","volume":"35","author":"Rocha","year":"2016","journal-title":"Rev. Port. Cardiol. (Engl. Ed.)"},{"key":"ref_18","unstructured":"(2024, May 05). U Prevent ADVANCE Risk Score. Available online: https:\/\/u-prevent.com\/calculators\/advanceScore."},{"key":"ref_19","unstructured":"(2024, May 07). WHO Consultation on Obesity 1999: World Health Organization Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation. Available online: https:\/\/iris.who.int\/handle\/10665\/42330."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2022). 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes\u20142022. Diabetes Care, 45, S144\u2013S174.","DOI":"10.2337\/dc22-S010"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"The SPRINT Research Group (2015). A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N. Engl. J. Med., 373, 2103.","DOI":"10.1056\/NEJMoa1511939"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"The ACCORD Study Group (2010). Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus. N. Engl. J. Med., 362, 1575.","DOI":"10.1056\/NEJMoa1001286"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Gourdy, P., Schiele, F., Halimi, J.M., Kownator, S., Hadjadj, S., and Valensi, P. (2023). Atherosclerotic Cardiovascular Disease Risk Stratification and Management in Type 2 Diabetes: Review of Recent Evidence-Based Guidelines. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1227769"},{"key":"ref_24","unstructured":"(2024, May 06). PORDATA Instituto Nacional de Estat\u00edstica I.P. Resident Population Aged 15 and over by Level of Education Completed. Available online: https:\/\/www.pordata.pt\/."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Kim, M.K., Lee, K.N., Han, K., and Lee, S.-H. (2024). Diabetes Duration, Cholesterol Levels, and Risk of Cardiovascular Diseases in Individuals With Type 2 Diabetes. J. Clin. Endocrinol. Metab., dgae092.","DOI":"10.1210\/clinem\/dgae092"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"109899","DOI":"10.1016\/j.diabres.2022.109899","article-title":"Duration of Diabetes and the Risk of Major Cardiovascular Events in Women and Men: A Prospective Cohort Study of UK Biobank Participants","volume":"188","author":"Woodward","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Yao, X., Zhang, J., Zhang, X., Jiang, T., Zhang, Y., Dai, F., Hu, H., and Zhang, Q. (2023). Age at Diagnosis, Diabetes Duration and the Risk of Cardiovascular Disease in Patients with Diabetes Mellitus: A Cross-Sectional Study. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1131395"},{"key":"ref_29","unstructured":"WHO (2022). WHO European Regional Obesity Report 2022, WHO Regional Office for Europe. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.orcp.2017.08.002","article-title":"Prevalence of Overweight and Obesity in Portugal: Results from the First Portuguese Health Examination Survey (INSEF 2015)","volume":"12","author":"Gaio","year":"2018","journal-title":"Obes. Res. Clin. Pract."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Oliveira, A., Ara\u00fajo, J., Severo, M., Correia, D., Ramos, E., Torres, D., Lopes, C., Rodrigues, S., Vilela, S., and Guiomar, S. (2018). Prevalence of General and Abdominal Obesity in Portugal: Comprehensive Results from the National Food, Nutrition and Physical Activity Survey 2015\u20132016. BMC Public Health, 18.","DOI":"10.1186\/s12889-018-5480-z"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Gonz\u00e1lez, M.A., Garc\u00eda-Arellano, A., Toledo, E., Bes-Rastrollo, M., Bull\u00f3, M., Corella, D., Fito, M., Ros, E., Lamuela-Ravent\u00f3s, R.M., and Rekondo, J. (2014). Obesity Indexes and Total Mortality among Elderly Subjects at High Cardiovascular Risk: The PREDIMED Study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0103246"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.vhri.2015.03.002","article-title":"A Systematic Review of Community Pharmacists\u2019 Interventions in Reducing Major Risk Factors for Cardiovascular Disease","volume":"7","author":"Chiazor","year":"2015","journal-title":"Value Health Reg. Issues"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Hu, C., Lin, L., Zhu, Y., Zhang, Y., Wang, S., Zhang, J., Qi, H., Li, M., Zhu, Y., and Huo, Y. (2021). Association Between Age at Diagnosis of Type 2 Diabetes and Cardiovascular Diseases: A Nationwide, Population-Based, Cohort Study. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.717069"},{"key":"ref_35","unstructured":"Instituto Nacional Estat\u00edstica (2020). Inqu\u00e9rito Nacional de Sa\u00fade 2019, Instituto Nacional de Estat\u00edstica."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.diabres.2003.12.003","article-title":"Variability in the Presence of the Metabolic Syndrome in Type 2 Diabetic Patients Attending a Diabetes Clinic: Influences of Age and Gender","volume":"65","author":"Relimpio","year":"2004","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.diabres.2003.12.002","article-title":"Cardiovascular Risk Factors in Patients with Type 2 Diabetes: Do We Follow the Guidelines?","volume":"65","year":"2004","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"103162","DOI":"10.1016\/j.amsu.2021.103162","article-title":"The Prevalence of Hypertension and Its Progression among Patients with Type 2 Diabetes in Jordan","volume":"73","author":"Salameh","year":"2022","journal-title":"Ann. Med. Surg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"103758","DOI":"10.1016\/j.amsu.2022.103758","article-title":"Prevalence of Hypertension in Type-2 Diabetes Mellitus","volume":"78","author":"Naseri","year":"2022","journal-title":"Ann. Med. Surg."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11892-019-1212-8","article-title":"Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes","volume":"19","author":"Hicks","year":"2019","journal-title":"Curr. Diab Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1210\/er.2015-1137","article-title":"Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus","volume":"37","author":"Harreiter","year":"2016","journal-title":"Endocr. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.repc.2022.04.011","article-title":"High Prevalence of Cardiovascular Disease and Risk Factors among Type 2 Diabetes Patients Followed in a Hospital Setting in Portugal: The PICT2RE Observational Study","volume":"42","author":"Cardoso","year":"2023","journal-title":"Rev. Port. Cardiol."},{"key":"ref_43","unstructured":"SCORE2 working group, and ESC Cardiovascular risk collaboration (2021). SCORE2 Risk Prediction Algorithms: New Models to Estimate 10-Year Risk of Cardiovascular Disease in Europe. Eur. Heart J., 42, 2439\u20132454."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(20)32332-1","article-title":"Efficacy and Safety of Lowering LDL Cholesterol in Older Patients: A Systematic Review and Meta-Analysis of Randomised Controlled Trials","volume":"396","author":"Gencer","year":"2020","journal-title":"Lancet"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"SCORE2-OP Working Group (2021). ESC Cardiovascular Risk SCORE2-OP Risk Prediction Algorithms: Estimating Incident Cardiovascular Event Risk in Older Persons in Four Geographical Risk Regions. Eur. Heart J., 42, 2455\u20132467.","DOI":"10.1093\/eurheartj\/ehab312"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"376","DOI":"10.5830\/CVJA-2013-078","article-title":"The ADVA NCE Cardiovascular Risk Model and Current Strategies for Cardiovascular Disease Risk Evaluation in People with Diabetes","volume":"24","author":"Kengne","year":"2013","journal-title":"Cardiovasc. J. Afr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/1741826710394270","article-title":"Contemporary Model for Cardiovascular Risk Prediction in People with Type 2 Diabetes","volume":"18","author":"Kengne","year":"2011","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1177\/2047487319846715","article-title":"Risk Prediction Tools in Cardiovascular Disease Prevention: A Report from the ESC Prevention of CVD Programme Led by the European Association of Preventive Cardiology (EAPC) in Collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP)","volume":"26","author":"Rossello","year":"2019","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Kweon, Y.N., Ko, H.J., Kim, A.S., Choi, H.I., Song, J.E., Park, J.Y., Kim, S.M., Hong, H.E., and Min, K.J. (2021). Prediction of Cardiovascular Risk Using Nonalcoholic Fatty Liver Disease Scoring Systems. Healthcare, 9.","DOI":"10.3390\/healthcare9070899"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., and Tiribelli, C. (2006). The Fatty Liver Index: A Simple and Accurate Predictor of Hepatic Steatosis in the General Population. BMC Gastroenterol., 6.","DOI":"10.1186\/1471-230X-6-33"},{"key":"ref_51","unstructured":"(2024, May 06). U-Prevent. Available online: https:\/\/u-prevent.com\/calculators\/dialModel."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/eurjpc\/zwac232","article-title":"Estimating Individual Lifetime Risk of Incident Cardiovascular Events in Adults with Type 2 Diabetes: An Update and Geographical Calibration of the DIAbetes Lifetime Perspective Model (DIAL2)","volume":"30","author":"Hageman","year":"2023","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/CLEP.S391749","article-title":"Associations Between Mean HbA1c, HbA1c Variability, and Both Mortality and Macrovascular Complications in Patients with Diabetes Mellitus: A Registry-Based Cohort Study","volume":"15","author":"Tan","year":"2023","journal-title":"Clin. Epidemiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1007\/s12325-022-02106-4","article-title":"The Association Between Sustained HbA1c Control and Long-Term Complications Among Individuals with Type 2 Diabetes: A Retrospective Study","volume":"39","author":"Boye","year":"2022","journal-title":"Adv. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"110069","DOI":"10.1016\/j.diabres.2022.110069","article-title":"Mean HbA1c and HbA1c Variability Are Associated with Differing Diabetes-Related Complications in Patients with Type 2 Diabetes Mellitus","volume":"192","author":"Wu","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12933-021-01401-8","article-title":"Improvement of Glycemic Control and Reduction of Major Cardiovascular Events in 18 Cardiovascular Outcome Trials: An Updated Meta-Regression","volume":"20","author":"Maiorino","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2024). 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes\u20142024. Diabetes Care, 47, S111\u2013S125.","DOI":"10.2337\/dc24-S006"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1177\/2047487318770519","article-title":"Health Literacy: Is It Important for Cardiovascular Disease Prevention?","volume":"25","author":"Albus","year":"2018","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Wang, H., Liu, J., Feng, Y., Ma, A., and Wang, T. (2023). The Burden of Cardiovascular Diseases Attributable to Metabolic Risk Factors and Its Change from 1990 to 2019: A Systematic Analysis and Prediction. Front. Epidemiol., 3.","DOI":"10.3389\/fepid.2023.1048515"}],"container-title":["Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2673-4540\/5\/3\/24\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:28:04Z","timestamp":1760110084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2673-4540\/5\/3\/24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":59,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["diabetology5030024"],"URL":"https:\/\/doi.org\/10.3390\/diabetology5030024","relation":{},"ISSN":["2673-4540"],"issn-type":[{"value":"2673-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]}}}